Sheria Hudson
Adult Health · Glen Mills, PANPI 1831314400
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.1% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,448 and has fallen 82.0% since, to $442 in 2025. Among adult health clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$1K
- AbbVie$796
- Pfizer$290
- Teva Pharmaceuticals USA, Inc.$287
- Harmony Biosciences LLC$258
- SK Life Science, Inc.$238
- plus $3K from 30 others
What the payments were for
- Consulting fees$3005%
- Food & beverage$5,04592%
- Education$1352%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 32 | $1,047 |
| AbbVie | 50 | $796 |
| Pfizer | 23 | $290 |
| Teva Pharmaceuticals USA, Inc. | 14 | $287 |
| Harmony Biosciences LLC | 10 | $258 |
| SK Life Science, Inc. | 10 | $238 |
| Jazz Pharmaceuticals Inc. | 11 | $227 |
| Johnson & Johnson | 6 | $215 |
| Novartis | 11 | $206 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $189 |
| Amgen | 7 | $188 |
| Lundbeck LLC | 7 | $182 |
| AstraZeneca | 9 | $158 |
| Axsome Therapeutics, Inc. | 2 | $142 |
| Lilly USA, LLC | 7 | $112 |
| Impel Pharmaceuticals Inc. | 4 | $92 |
| Genentech USA, Inc. | 4 | $90 |
| EMD Serono, Inc. | 5 | $85 |
| Avanir Pharmaceuticals, Inc. | 3 | $63 |
| Argenx US, Inc. | 2 | $63 |
| Acadia Pharmaceuticals Inc | 3 | $55 |
| UCB, Inc. | 2 | $49 |
| Boston Scientific | 2 | $47 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Sunovion Pharmaceuticals Inc. | 2 | $42 |
| Sanofi | 2 | $42 |
| Acorda Therapeutics, Inc | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Merz Pharmaceuticals, LLC | 1 | $36 |
| Alnylam Pharmaceuticals Inc. | 1 | $33 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
| Eisai Inc. | 1 | $22 |
| Neurelis, Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,481 in reported general payments places this provider in the 90th percentile of 899 adult health providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 25 | $29,692 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $19,301 |
| Emgality PenGalcanezumab-Gnlm | 18 | $14,961 |
| Lacosamide | 30 | $6,432 |
| Memantine Hcl | 146 | $4,719 |
| Gabapentin | 124 | $3,991 |
| Levetiracetam | 64 | $2,316 |
| Rivastigmine | 22 | $2,032 |
| Donepezil Hcl | 164 | $1,784 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 46 | $1,613 |
| Lamotrigine | 73 | $1,488 |
| Pregabalin | 54 | $1,476 |
| Carbamazepine ErCarbamazepine | 19 | $1,363 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 49 | $1,287 |
| Divalproex Sodium | 27 | $1,272 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $290 | $29,69225 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 899 adult health providers in Pennsylvania.
Other adult health in Glen Mills
- Julia KasperGlen Mills$7K
- Beth SandyPhiladelphia$924K
- Jennifer MondilloSchwenksville$396K
- Diane NewmanPhiladelphia$343K
- Elizabeth FaustDouglassville$342K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Jennifer KeeleyWexford$97K
- Debra EvansFarrell$85K
- Bethann MallonBlue Bell$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.